Oblenio Bio
Delivering a broad immune system reset
Cambridge, United States · Founded 2024 · $62.0M raised
- Headquarters
- Cambridge
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2B
- Website
- obleniobio.com
- Total Funding
- $62.0M
- Last Round
- $62.0M Series BJun 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Oblenio Bio is a Cambridge, Massachusetts-based clinical-stage biotechnology company pursuing a broad immune reset approach for refractory autoimmune diseases. The company's lead asset, LBL-051, is a first-in-class tri-specific T-cell engager antibody that simultaneously targets BCMA, CD19, and CD3 to deplete pathological B-cells and plasma cells across a wide spectrum of autoimmune conditions. Formed in November 2024 as a joint venture between Aditum Bio and Leads Biolabs, Oblenio Bio is led by proven drug developers with the goal of achieving long-term, drug-free remission for patients with severe autoimmune disease who have exhausted existing therapies. The company closed a $62 million Series B in June 2026 led by Pfizer Ventures to advance LBL-051 into clinical development.
Summary
Oblenio Bio is a Biotech company based in Cambridge, United States, founded in 2024. It has raised $62.0M in total across 1 round, most recently a $62.0M Series B round in Jun 2026. Investors include Pfizer Ventures, Deep Track Capital and GV.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2026
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oblenio-bio"><img src="https://indexed.vc/api/badge/company/oblenio-bio" alt="Oblenio Bio on Indexed.vc" width="260" height="76" /></a>